Key positives include consistent and accelerating revenue growth, significant margin expansion, and a strong recovery in cash generation after a major acquisition. The company holds a leading position in healthcare education, a field with chronic workforce shortages, and it has deep regulatory experience, broad clinical partnerships, and growing technology capabilities in areas like AI and simulation. Together, these factors suggest a business with real scale advantages and improving financial quality.

Main concerns center on the balance sheet and the sector backdrop. The heavy concentration of goodwill and other intangibles raises the risk of future write-downs if acquired assets underperform. Leverage, while improving, remains notably higher than before the acquisition, and liquidity is relatively tight, making the company reliant on continued strong cash flows. The for-profit education sector also carries regulatory, political, and reputational risks, and large share repurchases reduce financial flexibility if conditions worsen.

Looking ahead, the financial and strategic trajectory appears favorable but not without caveats. Structural demand for healthcare professionals, coupled with the company’s scaled, specialized platform and technology investments, supports a constructive view on its growth potential. At the same time, sustaining that trajectory will require careful management of leverage and liquidity, successful execution of AI and digital initiatives, consistent student outcomes, and close attention to regulatory developments that could quickly alter the operating environment.